title: Decline of disease activity and autoantibodies to desmoglein 3 and envoplakin by oral prednisolone in paraneoplastic pemphigus with benign thymoma.
authors.forename: Norito
authors.initials: N
authors.lastname: Ishii
authors.forename: Takahiro
authors.initials: T
authors.lastname: Hamada
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Koga
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Sogame
authors.forename: Bungo
authors.initials: B
authors.lastname: Ohyama
authors.forename: Shunpei
authors.initials: S
authors.lastname: Fukuda
authors.forename: Yohei
authors.initials: Y
authors.lastname: Natsuaki
authors.forename: Teruki
authors.initials: T
authors.lastname: Dainichi
authors.forename: Tadashi
authors.initials: T
authors.lastname: Karashima
authors.forename: Takekuni
authors.initials: T
authors.lastname: Nakama
authors.forename: Daisuke
authors.initials: D
authors.lastname: Tsuruta
authors.forename: Takashi
authors.initials: T
authors.lastname: Hashimoto
mesh_terms: D000284:Administration, Oral; D000368:Aged; D001323:Autoantibodies / Q000032:analysis; D051184:Desmoglein 3 / Q000276:immunology*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008565:Membrane Proteins / Q000276:immunology*; D010257:Paraneoplastic Syndromes / Q000276:immunology*; D010392:Pemphigus / Q000150:complications / Q000188:drug therapy* / Q000276:immunology*; D011239:Prednisolone / Q000008:administration & dosage*; D011498:Protein Precursors / Q000276:immunology*; D013945:Thymoma / Q000150:complications / Q000276:immunology*; D013953:Thymus Neoplasms / Q000150:complications / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D051184:Desmoglein 3; D005938:Glucocorticoids; D008565:Membrane Proteins; D011498:Protein Precursors; C100754:envoplakin; D011239:Prednisolone